9-95508364-TGCCGCCGCCGCC-TGCC

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2

The NM_000264.5(PTCH1):​c.-12_-4delGGCGGCGGC variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000637 in 1,163,798 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00055 ( 0 hom., cov: 22)
Exomes 𝑓: 0.00065 ( 1 hom. )

Consequence

PTCH1
NM_000264.5 5_prime_UTR

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 3.30

Publications

2 publications found
Variant links:
Genes affected
PTCH1 (HGNC:9585): (patched 1) This gene encodes a member of the patched family of proteins and a component of the hedgehog signaling pathway. Hedgehog signaling is important in embryonic development and tumorigenesis. The encoded protein is the receptor for the secreted hedgehog ligands, which include sonic hedgehog, indian hedgehog and desert hedgehog. Following binding by one of the hedgehog ligands, the encoded protein is trafficked away from the primary cilium, relieving inhibition of the G-protein-coupled receptor smoothened, which results in activation of downstream signaling. Mutations of this gene have been associated with basal cell nevus syndrome and holoprosencephaly. [provided by RefSeq, Aug 2017]
PTCH1 Gene-Disease associations (from GenCC):
  • basal cell nevus syndrome 1
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • holoprosencephaly 7
    Inheritance: AD Classification: DEFINITIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • nevoid basal cell carcinoma syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
  • holoprosencephaly
    Inheritance: AD Classification: LIMITED Submitted by: Illumina

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 9-95508364-TGCCGCCGCC-T is Benign according to our data. Variant chr9-95508364-TGCCGCCGCC-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 215454.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAdExome4 allele frequency = 0.000649 (659/1015956) while in subpopulation NFE AF = 0.000628 (552/878566). AF 95% confidence interval is 0.000585. There are 1 homozygotes in GnomAdExome4. There are 308 alleles in the male GnomAdExome4 subpopulation. This position passed quality control check.
BS2
High AC in GnomAd4 at 82 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PTCH1NM_000264.5 linkc.-12_-4delGGCGGCGGC 5_prime_UTR_variant Exon 1 of 24 ENST00000331920.11 NP_000255.2 Q13635-1
PTCH1NM_001083603.3 linkc.199-1774_199-1766delGGCGGCGGC intron_variant Intron 1 of 23 ENST00000437951.6 NP_001077072.1 Q13635-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PTCH1ENST00000331920.11 linkc.-12_-4delGGCGGCGGC 5_prime_UTR_variant Exon 1 of 24 5 NM_000264.5 ENSP00000332353.6 Q13635-1
PTCH1ENST00000437951.6 linkc.199-1774_199-1766delGGCGGCGGC intron_variant Intron 1 of 23 5 NM_001083603.3 ENSP00000389744.2 Q13635-2

Frequencies

GnomAD3 genomes
AF:
0.000555
AC:
82
AN:
147736
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.000271
Gnomad AMI
AF:
0.00112
Gnomad AMR
AF:
0.000603
Gnomad ASJ
AF:
0.00235
Gnomad EAS
AF:
0.000604
Gnomad SAS
AF:
0.000421
Gnomad FIN
AF:
0.00128
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000542
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000670
AC:
1
AN:
1492
AF XY:
0.00116
show subpopulations
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000790
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000649
AC:
659
AN:
1015956
Hom.:
1
AF XY:
0.000641
AC XY:
308
AN XY:
480704
show subpopulations
African (AFR)
AF:
0.000446
AC:
9
AN:
20162
American (AMR)
AF:
0.000604
AC:
4
AN:
6622
Ashkenazi Jewish (ASJ)
AF:
0.00270
AC:
30
AN:
11094
East Asian (EAS)
AF:
0.000431
AC:
9
AN:
20892
South Asian (SAS)
AF:
0.000578
AC:
11
AN:
19040
European-Finnish (FIN)
AF:
0.000825
AC:
15
AN:
18176
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2568
European-Non Finnish (NFE)
AF:
0.000628
AC:
552
AN:
878566
Other (OTH)
AF:
0.000747
AC:
29
AN:
38836
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
30
60
90
120
150
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000555
AC:
82
AN:
147842
Hom.:
0
Cov.:
22
AF XY:
0.000639
AC XY:
46
AN XY:
72038
show subpopulations
African (AFR)
AF:
0.000270
AC:
11
AN:
40744
American (AMR)
AF:
0.000602
AC:
9
AN:
14952
Ashkenazi Jewish (ASJ)
AF:
0.00235
AC:
8
AN:
3398
East Asian (EAS)
AF:
0.000606
AC:
3
AN:
4948
South Asian (SAS)
AF:
0.000421
AC:
2
AN:
4752
European-Finnish (FIN)
AF:
0.00128
AC:
12
AN:
9392
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
290
European-Non Finnish (NFE)
AF:
0.000542
AC:
36
AN:
66430
Other (OTH)
AF:
0.00
AC:
0
AN:
2046
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
4
7
11
14
18
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
138

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Mar 09, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 29, 2022
Quest Diagnostics Nichols Institute San Juan Capistrano
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Gorlin syndrome Benign:1
Aug 26, 2015
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary cancer-predisposing syndrome Benign:1
Apr 06, 2022
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
3.3
Mutation Taster
=271/29
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs71366293; hg19: chr9-98270646; API